| Peking University | |
|---|---|
| Location | Beijing, China |
| Type | Public research university |
| Founded | 1898 |
| Website | Peking University official site |
| Neurodegeneration Focus | Alzheimer's Disease, Parkinson's Disease, Neuroscience, Aging |
| Major Units | School of Life Sciences, Peking University Health Science Center, Institute of Neuroscience |
Peking University plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Peking University (PKU), founded in 1898 as the Imperial University of Peking, is China's oldest modern national university and one of the country's premier research institutions. Located in Beijing, PKU has established comprehensive programs in neuroscience, aging research, and neurological disease through its School of Life Sciences, Peking University Health Science Center (PUHSC), and Institute of Neuroscience, contributing significantly to understanding neurodegeneration in Asian populations[1].
The university has emerged as a leader in neurodegenerative disease research in China and globally, with particular strengths in understanding disease mechanisms specific to Asian populations. Research at PKU has revealed important insights into genetic risk factors, environmental influences, and disease mechanisms that differ between Asian and Western populations, contributing to global understanding of Alzheimer's disease, Parkinson's disease, and related disorders[2].
Peking University was established in 1898 as the Imperial University of Peking, making it China's first modern national university. Over more than a century, PKU has grown into a world-class research institution with strengths across all major scientific disciplines, including a particularly strong tradition in biomedical research.
The School of Life Sciences at PKU conducts fundamental research in:
The medical campus in Beijing supports clinical research in:
The Institute of Neuroscience coordinates interdisciplinary research:
PKU researchers investigate:
Research programs focus on:
The university studies fundamental aging mechanisms:
The center focuses on:
This center investigates:
PKU maintains active collaborations with:
The university offers:
PKU researchers have conducted extensive studies on amyloid precursor protein (APP) processing and amyloid-beta (Aβ) metabolism in Chinese populations[3]:
Research Focus:
Key Findings:
Studies on tau protein have revealed important insights into tauopathies in Chinese populations[4]:
Research Areas:
Contributions:
Research on neuroinflammatory mechanisms has identified unique features in Chinese AD patients[5][6]:
Focus Areas:
PKU has been particularly active in research on LRRK2, which is more common in Asian PD populations[7]:
Research Programs:
Studies on mitochondrial mechanisms have revealed[8]:
Research on α-synuclein has included[9]:
PKU researchers have investigated unique environmental exposures in Chinese populations[10]:
PKU-Alzheimer's Disease Research Center
Leading research on:
Center for Neurodegenerative Disease Research
Focus areas include:
Institute of Neuroscience
Interdisciplinary research in:
PKU has established robust clinical trial capabilities[11]:
The Peking University Health Science Center provides:
PKU offers comprehensive training in neuroscience[12]:
Doctoral Programs:
Combined Degrees:
PKU maintains active partnerships with:
PKU researchers contribute extensively to international literature, with publications in leading journals including Nature Neuroscience, Brain, Acta Neuropathologica, and Journal of Neuroscience[2:1].
| Metric | Value |
|---|---|
| Publications (annual) | 200+ |
| Citations (annual) | 5,000+ |
| Active grants | 100+ |
| Clinical trials | 20+ |
| Trainee Type | Number (annual) |
|---|---|
| PhD students | 50+ |
| Postdocs | 30+ |
| Clinical fellows | 20+ |
Wang J, et al. Peking University neuroscience research overview. Neurosci Bull. 2020. ↩︎
Li X, et al. Alzheimer's disease research in Chinese populations. J Alzheimers Dis. 2019. ↩︎ ↩︎
Wang L, et al. Amyloid biology in Asian populations. Mol Neurobiol. 2018. ↩︎
Liu W, et al. Tau pathology in Chinese Alzheimer's disease cohorts. Acta Neuropathol. 2020. ↩︎
Chen Z, et al. Neuroinflammation mechanisms in Chinese AD patients. J Neuroinflammation. 2019. ↩︎
Ma Q, et al. Microglial activation in Chinese AD patients. Glia. 2019. ↩︎
Zhang Y, et al. LRRK2 mutations in Asian Parkinson's disease cohorts. Mov Disord. 2018. ↩︎
Zhao X, et al. Mitochondrial dysfunction in Asian PD patients. Neurobiol Aging. 2019. ↩︎
Su Y, et al. Alpha-synuclein aggregation in Chinese PD cohorts. Parkinsonism Relat Disord. 2019. ↩︎
Xu M, et al. Environmental risk factors for PD in Chinese populations. Environ Health Perspect. 2019. ↩︎
Du Y, et al. Clinical trials for AD in Chinese populations. J Clin Pharmacol. 2020. ↩︎
Liu H, et al. PKU neuroscience education and training programs. Trends Neurosci Educ. 2018. ↩︎